MoneyWorks4Me

Kopran - Quaterly Results

15 May 2025 Evaluate
The sales declined to Rs. 759.35 millions for the March 2025 quarter as compared to Rs. 906.23 millions during the corresponding quarter last year.Net Profit of the company move down -43.84% to Rs. 85.98  millions from Rs. 153.09 millions  in the same quarter last year.A decline of 142.04 millions was observed in the OP in the quarter ended March 2025 from 234.90 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 759.35 906.23 -16.21 2710.10 3374.56 -19.69 2710.10 3374.56 -19.69
Other Income 19.18 81.49 -76.46 59.04 167.11 -64.67 59.04 167.11 -64.67
PBIDT 142.04 234.90 -39.53 445.60 536.37 -16.92 445.60 536.37 -16.92
Interest 12.58 17.79 -29.29 37.66 45.01 -16.33 37.66 45.01 -16.33
PBDT 129.46 217.11 -40.37 407.94 491.36 -16.98 407.94 491.36 -16.98
Depreciation 12.39 11.62 6.63 49.99 46.20 8.20 49.99 46.20 8.20
PBT 117.07 205.49 -43.03 357.95 445.16 -19.59 357.95 445.16 -19.59
TAX 31.09 52.40 -40.67 89.38 98.79 -9.53 89.38 98.79 -9.53
Deferred Tax 3.74 0.10 3640.00 3.06 -2.03 -250.74 3.06 -2.03 -250.74
PAT 85.98 153.09 -43.84 268.57 346.37 -22.46 268.57 346.37 -22.46
Equity 482.86 482.11 0.16 482.86 482.11 0.16 482.86 482.11 0.16
PBIDTM(%) 18.71 25.92 -27.84 16.44 15.89 3.45 16.44 15.89 3.45
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..